We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About International PCV Conference

International PCV conference ‘PCV – 25 Years On’

1st International PCV conference ‘PCV – 25 Years On’, a one day meeting, supported by Novartis, taking place in Bangkok, Thailand on 7th December 2016.

Through a program of plenary lectures, panel discussions, case studies and debates, our panel of experts will provide a timely and insightful exposition into polypoidal choroidal vasculopathy (PCV) – first identified as a specific pathology 25 years ago and one of the most challenging conditions in retinal care today. Presentation and discussion topics will include diagnosis, pathophysiology, genetics, epidemiology and treatment of PCV. New imaging techniques will be discussed, as well as the latest findings from clinical trials and epidemiological studies in PCV. A highlight of the day will be a debate on the best approach for the initial treatment of the condition, in newly diagnosed patients. The day will close with a series of Free Paper presentations in the field of PCV.

We warmly encourage your participation, in what we anticipate will be a dynamic and informative scientific meeting.

What's New in the Latest Version 1.18.2+4

Last updated on Nov 25, 2016

bugfixes and performance improvements

Translation Loading...

Additional APP Information

Latest Version

Request International PCV Conference Update 1.18.2+4

Uploaded by

Dicky Renata

Requires Android

Android 4.1+

Show More

International PCV Conference Screenshots

Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.